Physician profile
Han Cheng
NPI 1083617682
$1,972.18
in general payments reported to CMS, 2019-2025
13 companies · $561 in 2025
The $561 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2021: $16.35 · 2022: $56.01 · 2023: $465 · 2024: $612 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646 · Consulting Fee: $600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Entertainment: $92.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.50 |
| Consulting Fee | $600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Entertainment | $92.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $401.58 | 2023-2025 | Clariti Contact Lens, Paragon Crt |
| Alcon Vision LLC | $386.75 | 2019-2025 | Air Optix |
| Johnson & Johnson Vision Care, INC. | $343.18 | 2024-2025 | Acuvue |
| Emd Serono, INC. | $336.79 | 2019-2023 | |
| Carl Zeiss Meditec USA, INC. | $123.41 | 2023 | |
| Glaukos Corporation | $105.25 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $97.66 | 2024 | |
| Optos, INC. | $92.14 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $23.22 | 2025 | Infuse |
| Spark Therapeutics, INC. | $19.76 | 2019 | |
| Dompe US, INC. | $16.35 | 2021 | |
| Apellis Pharmaceuticals, INC. | $13.55 | 2024 | Syfovre |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Han Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.